Cytokinetics share price

Author: lqjg

August undefined, 2024

WebApr 11, 2024 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. Web12 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts …

CYTK - Cytokinetics Inc Stock quote - CNNMoney.com

WebApr 6, 2024 · Buy Cytokinetics Inc Shares from India at $36.17 (0 Commission) today. Start investing in Cytokinetics Inc stocks from India now with fractional investing only on INDmoneyapp WebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ip2int

Analysts Have Conflicting Sentiments on These Healthcare …

WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate Web2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% from a day low at $33.88 to a day high of $35.91. The price has been going up and down for this period, and there has been a -2.66% loss for the last 2 weeks. WebView the latest Cytokinetics Inc. (CYTK) stock price, news, historical charts, analyst ratings and financial information from WSJ. ip2nd isis

CYTK Price Target 2024 Cytokinetics Analyst Ratings

Where will Cytokinetics Stock Be In 1 Year? – Financhill

WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … opening the meeting phrasesWebNov 8, 2024 · The cap price of the capped call transactions will initially be approximately $14.07 per share, which represents a premium of approximately 70% over the per share closing price of Cytokinetics’s ... ip2 initiative france

"WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. " - Cytokinetics share price

Cytokinetics share price

Estimating The Fair Value Of Cytokinetics, Incorporated …

Web18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... WebGet Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Did you know?

WebAug 8, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 327% in the last half decade, a handsome return for long term holders. If that doesn't get you thinking about ... WebApr 12, 2024 · Oppenheimer cut their target price on shares of Cytokinetics from $55.00 to $54.00 and set an “outperform” rating for the company in a research note on Wednesday, March 1st.

WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cytokinetics Inc’s P/E ratio is -8.23.

WebMar 31, 2024 · CYTK: Get the latest Cytokinetics stock price and detailed information including CYTK news, historical charts and realtime prices. Menu icon A vertical stack of … WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend … NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance …

WebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. CYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets

WebFeb 26, 2024 · Cytokinetics Share Price & Price History. Current Price: $ 35.19 Price Change: Price Increase of +0.98 (2.86%) As of 03/31/2024 01:00 AM ET. This chart shows the closing price history over time for CYTK up to the past year. Skip Chart and Table Data Price Data in Insider Trading History Table. opening theme ost captain underpantsWebApr 6, 2024 · A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ip2ir global cacheWebCYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes 35.31 BATS BZX Real … ip2intc_irptWebFeb 24, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 442% in the last half decade, a handsome return for long term holders. And this is just one example of the epic gains achieved by some long term investors. On the other hand, the stock price has retraced 5.7% in the last week. opening theme from the wizard of ozWebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 … ip2network winWebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … opening theme once upon a time in the westWebApr 10, 2024 · Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Cytokinetics NasdaqGS:CYTK … ip 2 notes